Pelvic floor therapy for erectile dysfunction and premature ejaculation
Official title: Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.
Run by Boston Medical Group · NCT06425211 · Data updated 2026-11-12
This study is testing if pelvic floor therapy can help men with erectile dysfunction and premature ejaculation feel better after 12 weeks of treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | Men only |
| Enrollment | 66 (estimated) |
| Sponsor | Boston Medical Group Industry-sponsored |
| Locations | 1 site (Bogotá, Cundinamarca) |
| Status | Recruiting |
| Started | October 30, 2021 |
| Main results expected | June 2026 |
| Study ends | December 2026 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT06425211 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men over 18 with erectile dysfunction or premature ejaculation lasting at least 6 months and who engage in sexual activity at least once a week.
✕Probably not a fit
Patients currently receiving pharmacological treatment for erectile dysfunction or premature ejaculation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of pelvic floor therapy, which includes electrostimulation, biofeedback, and therapeutic exercises, for managing erectile dysfunction and premature ejaculation. Participants will undergo an initial consultation, receive 24 therapy sessions over 12 weeks, and have follow-up evaluations at 3 and 6 months. The study includes three groups: those with premature ejaculation, those with erectile dysfunction, and those with both conditions. The primary outcomes will assess changes in erectile function and intravaginal latency time.
Why it matters
Potential benefit: If successful, this therapy could provide a non-pharmacological treatment option for men suffering from erectile dysfunction and premature ejaculation.
How similar studies have gone: While pelvic floor therapy is a recognized approach, the specific combination of therapies in this trial is relatively novel and has not been extensively tested in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Overall: * Men over 18 years of age * Erectile dysfunction or premature ejaculation for at least 6 months * Sexual activity with a heterosexual partner at least once a week * Signing of informed consent before the start of the study For the premature ejaculation group: * Premature ejaculation according to the International Society of Sexual Medicine (ISSM) criteria * Premature Ejaculation Diagnosis Tool (PEDT) questionnaire score greater than 11 For the erectile dysfunction group: * Clinical diagnosis of primary erectile dysfunction * International Index Erectile Function - Erectile Function domain (IIEF-EF) score less than 26 Exclusion Criteria: * Pharmacological treatment for erectile dysfunction or premature ejaculation in the last 3 months * Erection Hardness Score (EHS) greater than 3 for patients with erectile dysfunction * History of hypogonadism or suspected hypogonadism due to Aging Males Symptoms (AMS) score greater than 36 for patients with erectile dysfunction * History of pelvic radiotherapy * Pacemaker or cardiac arrhythmia, epilepsy * History of spinal cord trauma or spinal surgeries. * Inability to attend therapies or controls * Illiteracy or cognitive disability that prevents you from completing the questionnaires * Psychiatric, psychological disorders, or cognitive deficiencies * Injuries in the area of application of the therapy * Active pelvic organ cancer
Where it's running
-
Boston Medical Group Colombia
Bogotá, Cundinamarca, Colombia Recruiting
Study contacts
- Principal investigator: Cristina Amaya — Boston Medical Group
- Study coordinator: Carolina Sandoval, Master
- Email: csandoval@bostonmedical.com.co
- Phone: +573133920816
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise for erectile dysfunction and premature ejaculation
This project tests whether an 8-week, three-times-weekly exercise program helps men aged 25–45 who have erectile dysfunction and premature ejaculation.
-
HIP2602 for Erectile Dysfunction: Testing a new treatment in adults
This study tests whether HIP2602, alone or with related formulations, can improve erectile function in adult men with long-standing erectile dysfunction who partner with the same adult female partner.
-
Platelet-Rich Plasma for Erectile Dysfunction After Prostate Surgery
This trial tests whether injecting a patient’s own platelet-rich plasma can improve erectile function in men who have persistent ED more than a year after nerve-sparing radical prostatectomy.
-
Pudendal artery plaque and erectile dysfunction in men with heart disease
A small study tests whether plaque in the internal pudendal arteries is linked to erectile function in men with coronary artery disease who are undergoing coronary angiography.
-
Piezoelectric Low-Intensity Shockwave Therapy for erectile dysfunction in PDE5i nonresponders
This study tests whether four weeks of low‑intensity, linear piezoelectric shockwave therapy can improve erectile function in men with ED who did not respond to PDE5 inhibitors.
-
Sexual function and quality of life in monogamous vs polygamous marriages among Egyptian men
This is a web-based survey to see if marital structure affects erectile function and sexual quality of life in Egyptian men who are married.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.